Atlas Trials

Metabolic Impact of Intermittent Fasting in Early Type 2 Diabetes

Clinical trial NCT05717127 · COMPLETED

Trial details

NCT number
NCT05717127
Sponsor
Mount Sinai Hospital, Canada
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2Obesity
Start date
2021-09-01
Primary completion
2023-06-01
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.